These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33878406)

  • 21. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Gjervan B; Rasmussen K; Vaaler A; Nordahl HM
    Atten Defic Hyperact Disord; 2013 Mar; 5(1):59-67. PubMed ID: 23104523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study.
    Jafferany M; Vander Stoep A; Dumitrescu A; Hornung RL
    Int J Dermatol; 2010 Jul; 49(7):784-9. PubMed ID: 20618498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
    Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
    Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidisciplinary and Holistic Models of Care for Patients With Dermatologic Disease and Psychosocial Comorbidity: A Systematic Review.
    Patel A; Jafferany M
    JAMA Dermatol; 2020 Jun; 156(6):686-694. PubMed ID: 32347896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders.
    Wilens T; Zulauf C; Martelon M; Morrison NR; Simon A; Carrellas NW; Yule A; Anselmo R
    J Clin Psychiatry; 2016 Jul; 77(7):940-7. PubMed ID: 27464314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants.
    Kaloyanides KB; McCabe SE; Cranford JA; Teter CJ
    Pharmacotherapy; 2007 May; 27(5):666-74. PubMed ID: 17461701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Amphetamine-Type Stimulants Among Emergency Department Patients With Untreated Opioid Use Disorder.
    Chawarski MC; Hawk K; Edelman EJ; O'Connor P; Owens P; Martel S; Coupet E; Whiteside L; Tsui JI; Rothman R; Cowan E; Richardson L; Lyons MS; Fiellin DA; D'Onofrio G
    Ann Emerg Med; 2020 Dec; 76(6):782-787. PubMed ID: 32782084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression and stimulant dependence: neurobiology and pharmacotherapy.
    Kosten TR; Markou A; Koob GF
    J Nerv Ment Dis; 1998 Dec; 186(12):737-45. PubMed ID: 9865811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant use and stimulant use disorders in Australia: findings from the National Survey of Mental Health and Wellbeing.
    Sara GE; Burgess PM; Harris MG; Malhi GS; Whiteford HA
    Med J Aust; 2011 Nov; 195(10):607-9. PubMed ID: 22107012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry.
    Lecomte T; Giguère CÉ; Cloutier B; Potvin S;
    J Dual Diagn; 2020; 16(2):260-270. PubMed ID: 31983294
    [No Abstract]   [Full Text] [Related]  

  • 37. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students.
    Sepúlveda DR; Thomas LM; McCabe SE; Cranford JA; Boyd CJ; Teter CJ
    J Pharm Pract; 2011 Dec; 24(6):551-60. PubMed ID: 22095577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription stimulant use is associated with earlier onset of psychosis.
    Moran LV; Masters GA; Pingali S; Cohen BM; Liebson E; Rajarethinam RP; Ongur D
    J Psychiatr Res; 2015 Dec; 71():41-7. PubMed ID: 26522870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.